EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures
13. Januar 2025 07:00 ET
|
EDAP TMS S.A.
Company Reports Preliminary Worldwide Record Fourth Quarter Sales of 11 Focal One Systems Record U.S. Fourth Quarter Focal One System Sales Record Number of U.S. Focal One Procedures, with...
EDAP Appoints Joshua H. Levine to Board of Directors
10. Januar 2025 07:00 ET
|
EDAP TMS S.A.
PDF Version AUSTIN, Texas, January 10, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced the appointment of Joshua H....
EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology
08. Januar 2025 07:00 ET
|
EDAP TMS S.A.
AUSTIN, Texas, January 8, 2025 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced that the first patient has been treated in a phase I/II PULS Trial...
Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer
04. Dezember 2024 09:10 ET
|
EDAP TMS S.A.
HIFI Study is the largest (N = 3,328) prospective, comparative, multi-center clinical study ever conducted comparing prostate cancer treatmentsPositive study results are expected to drive...
EDAP to Participate in the Piper Sandler 36th Annual Healthcare Conference
27. November 2024 07:00 ET
|
EDAP TMS S.A.
LYON, France, November 27, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer of EDAP TMS, is...
EDAP Announces Scientific Presentation Highlighting Feasibility of Focal One® to Perform Non-thermal Histotripsy Energy Delivery at the 187th Acoustical Society of America Meeting
22. November 2024 08:00 ET
|
EDAP TMS S.A.
Early feasibility work demonstrates Focal One system’s ability to generate histotripsy lesions ex vivo LYON, France, November 22, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in...
EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis
19. November 2024 08:00 ET
|
EDAP TMS S.A.
Treatment with robotic HIFU showed reduction in moderate and severe post-operative complications and reduced hospital stay compared to surgery LYON, France, November 19, 2024 - EDAP TMS...
EDAP Reports Third Quarter 2024 Financial Results
07. November 2024 07:00 ET
|
EDAP TMS S.A.
Reported Q3 worldwide revenue of EUR 13.1 million (USD 14.4 million), increasing 11.6% over Q3 2023Reported Q3 worldwide HIFU revenue of EUR 4.5 million (USD 4.9 million), increasing 48.2%...
EDAP to Participate in the 2024 Jefferies London Healthcare Conference
06. November 2024 08:00 ET
|
EDAP TMS S.A.
LYON, France, November 6, 2024 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, announced that Ryan Rhodes, Chief Executive Officer, is scheduled to...
EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024
24. Oktober 2024 08:00 ET
|
EDAP TMS S.A.
Company to host conference call and webcast on Thursday, November 7th at 8:30am EDT LYON, France, October 24, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic...